- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 209/36 - Oxygen atoms in position 3, e.g. adrenochrome
Patent holdings for IPC class C07D 209/36
Total number of patents in this class: 63
10-year publication summary
|
6
|
4
|
7
|
5
|
3
|
2
|
4
|
5
|
2
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Musc Foundation for Research Development | 337 |
5 |
| Biosynth AG | 60 |
4 |
| Azora Therapeutics, Inc. | 13 |
4 |
| Beth Israel Deaconess Medical Center, Inc. | 857 |
3 |
| Syntara Limited | 4 |
3 |
| Amira Pharmaceuticals, Inc. | 70 |
2 |
| U.S. Department of Veterans Affairs | 55 |
2 |
| New Mexico Tech University Research Park Corporation | 47 |
2 |
| Merck Sharp & Dohme LLC | 3755 |
2 |
| Bristol-myers Squibb Company | 4877 |
1 |
| Boehringer Ingelheim International GmbH | 4754 |
1 |
| Centre National de La Recherche Scientifique | 10158 |
1 |
| The General Hospital Corporation | 4659 |
1 |
| Georgia Tech Research Corporation | 2632 |
1 |
| Bionomics Limited | 88 |
1 |
| Board of Trustees of Southern Illinois University | 103 |
1 |
| The Broad Institute, Inc. | 1715 |
1 |
| Cambridge Display Technology Limited | 503 |
1 |
| Clark Atlanta University, Inc. | 9 |
1 |
| Consejo Superior de Investigaciones Cientificas | 907 |
1 |
| Other owners | 25 |